HDAC inhibition has also been shown to inhibit pathological cardiac hypertrophy and improve muscle contractility, as well as attenuate systolic and diastolic dysfunction [7,10,11,14,16,27]. Here, HDAC9 is linked to cardiac hypertrophy.